Logo
Call us: 91-11-42141242
Email: info@marketsmonitor.com
HOME COMPANY SECTORS CONTACTS
  • TO ACHIEVE HIGH PERFORMANCE

Chagas Cardiomyopathy Global C...

May, 2012 | 67 Pages | $800.00
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and
 

Covidien plc (COV) - Product P...

May, 2012 | 36 Pages | $750.00
Pharmaceuticals and Medical Supplies. Covidien has 339 facilities throughout the world which handle production, assembly,
 

Ferring Pharmaceuticals, Inc. ...

May, 2012 | 38 Pages | $500.00
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Ferring Pharmaceuticals, Inc.’s corporate website,
 

Industry: Generics

Healthcare Industry » Generics

Brain Hemorrhage – Pipeline Review, H1 2012

Mar, 2012  | Pages: 41
This report provides information on the therapeutic development for Brain Hemorrhage, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Brain

Approval of Kalydeco Brings New Hope for CF Patients with G551D Mutation

Feb, 2012  | Pages: 5
The report is an essential source of information and analysis on the KALYDECO (ivacaftor, VX-770) for the treatment of Cystic Fibrosis (CF) patients with G551D mutation. The report provides insights on the product clinical information and how it will brin

Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth

Jan, 2012  | Pages: 118
GBI Research, the leading business intelligence provider has released its latest research

Adrenoleukodystrophy - Pipeline Review, H2 2011

Dec, 2011  | Pages: 35
Global Markets Direct\'s, \'Adrenoleukodystrophy - Pipeline Review, H2 2011\', provides an overview of the Adrenoleukodystrophy therapeutic pipeline. This report provides information on the therapeutic development for Adrenoleukodystrophy, complete with l

Booming Generics Drug Market in India

Aug, 2011  | Pages: 60
Generic drugs market is anticipated to grow at a CAGR of around 17% during FY 2011- 2013 driven by patent expiries, investment, and private sector participation etc....

Global Genetic Testing Market Analysis

Aug, 2011  | Pages: 60
Increasing demand for newborn screening, high incidences of Alzheimer disease, breast cancer, etc will help genetic testing market to grow at a CAGR of around 26% during 2012-2015...

Global Obesity Drug Market Analysis

Jun, 2011  | Pages: 85
The obesity drug market is expected to be worth US$ 2.5 Billion by the end of 2014, growing at a CAGR of around 13% during 2011-2014.....

UK Generics Market Analysis

Apr, 2011  | Pages: 55
The UK is one of the largest economies in the world. The per capita income and spending has been also increasing for the last few years...

Booming US Generic Drug Market

Mar, 2011  | Pages: 60
The generics market in the US has good growth potential in various therapy segments, which have attracted investments and market revenue in recent times. In this regard, our report provides rational a

Japanese Generic Market Forecast to 2013

Mar, 2011  | Pages: 45
Backed by patent expiration of blockbuster drugs and active ingredients such as anastrozole, telmisartan, etc., generics market is projected to grow at a CAGR of around 8% during 2009-2013......
Pages:   1 2 Next Page  1  of  2   
 
 
 

Browse Catalogue

 Retail Industry Market Research Reports
 

Related Industries

Healthcare Industry
... more industries
 

Market PRs


By: www.marketpressrelease.com
 

Subscription

Receive email alerts of new market research reports in your industry. Subscribe Today
 
 
 US Office
822 East Evelyn Avenue
# 722 , Sunnyvale
CA, USA
Zip: 94087
Tel: +1-408-5308892
info@marketsmonitor.com
 India Office
Plot No. 55, FIE
Patparganj Industrial Area
Delhi, India - 110092
Tel:-+91-11-42141242
       +91-9811336614
info@marketsmonitor.com

Please Fill the Information

Name:
Email: *
Phone:
Company: